Gerardo Corigliano

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon et al. · Cardiovascular Diabetology · 2021 · 132 citations · Full text

Medicine, Internal Medicine, Nephrology +17

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero et al. · Cardiovascular Diabetology · 2022 · 73 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia

Sandro Gentile, Salvatore Turco, Giuseppina Guarino et al. · Diabetes Obesity and Metabolism · 2000 · 66 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Italian Diabetes and Exercise Study (IDES): Design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome

Stefano Balducci, Silvano Zanuso, Massimo Massarini et al. · Nutrition Metabolism and Cardiovascular Diseases · 2008 · 59 citations

Medicine, Endocrinology, Internal Medicine +17